Modulation of Thiopurine Metabolism by Anti-TNF Therapy

被引：0
|
作者：
Yoon, Jessica L.
Huang, Brian L.
Melmed, Gil Y.
Amin, Jaimin
Ippoliti, Andrew
Dubinsky, Marla
Khanna, Puja
Fleshner, Phillip
McGovern, Dermot P.
Targan, Stephan
Vasiliauskas, Eric A.
Shih, David Q.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1239
引用
收藏
页码：S239 / S240
页数：2
相关论文
共 50 条
  • [1] Potential Synergism Between Anti-TNF and Thiopurine Therapy: Increased Thiopurine Metabolites by Anti-TNF
    Yoon, Jessica L.
    Huang, Brian L.
    Karsan, Sundip S.
    Melmed, Gil Y.
    Ippoliti, Andrew
    Dubinsky, Marla
    Kaur, Manreet
    Minh Nguyen
    Vora, Puja
    Fleshner, Phillip
    McGovern, Dermot P.
    Targan, Stephan R.
    Vasiliauskas, Eric A.
    Shih, David Q.
    GASTROENTEROLOGY, 2013, 144 (05) : S772 - S773
  • [2] Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease
    Herrinton, Lisa J.
    Liu, Liyan
    Weng, Xiaoping
    Lewis, James D.
    Hutfless, Susan
    Allison, James E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (12): : 2146 - 2153
  • [3] Anti-TNF Therapy
    Udalova, Irina
    Monaco, Claudia
    Nanchahal, Jagdeep
    Feldmann, Marc
    MICROBIOLOGY SPECTRUM, 2016, 4 (04):
  • [4] Anti-TNF therapy
    Thalayasingam, Nishanthi
    Isaacs, John D.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2011, 25 (04): : 549 - 567
  • [5] Anti-TNF therapy and cancer
    Carmona, Loreto
    REUMATOLOGIA CLINICA, 2010, 6 (02): : 102 - 105
  • [6] Long-term effects of anti-TNF therapy on bone metabolism
    O'Morain, N.
    Farrell, G.
    Hanly, M.
    Veerappan, S.
    McNamara, D.
    Breslin, N.
    O'Morain, C.
    Healy, M.
    Ryan, B.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S339 - S339
  • [7] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [8] ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF THERAPY TO ADALIMUMAB, INFIXIMAB OR OTHER ANTI-TNF COMPARED WITH SWITCHING FROM ANTI-TNF THERAPY TO VEDOLIZUMAB
    Chiorean, Michael
    Afzali, Anita
    Cross, Raymond
    Zhou, Zhou
    Macaulay, Dendy
    Ganguli, Arijit
    Wang, Anthony
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S51 - S52
  • [9] LOWER MORTALITY RISK WITH COMBINATION THERAPY WITH ANTI-TNF THERAPY AND THRIOPURINE COMPARED TO THIOPURINE ALONE IN ELDERLY PATIENTS WITH UC
    Chaaban, Lara
    Kobeissi, Lynn
    Paul, Nicole
    Melia, Joanna
    GASTROENTEROLOGY, 2024, 166 (03) : S113 - S114
  • [10] LOWER MORTALITY RISK WITH COMBINATION THERAPY WITH ANTI-TNF THERAPY AND THRIOPURINE COMPARED TO THIOPURINE ALONE IN ELDERLY PATIENTS WITH UC
    Chaaban, Lara
    Kobeissi, Lynn
    Paul, Nicole
    Melia, Joanna
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S81 - S82
12345